Vitamin D—A prominent immunomodulator to prevent COVID‐19 infection
International Journal of Rheumatic Diseases, Volume 26, Issue 1, Page 13-30, January 2023., 2023 Abstract COVID‐19 remains a life‐threatening infectious disease worldwide. Several bio‐active agents have been tested and evaluated in an effort to contain this disease. Unfortunately, none of the therapies have been successful, owing to their safety concerns and the presence of various adverse effects.
Sumel Ashique +13 more
wiley +1 more source
Thromboembolic and bleeding events in ICU patients with COVID‐19: A nationwide, observational study
Acta Anaesthesiologica Scandinavica, Volume 67, Issue 1, Page 76-85, January 2023., 2023 Abstract Background Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID‐19) have an increased risk of thromboembolic complications. We describe the occurrence of thromboembolic and bleeding events in all ICU patients with COVID‐19 in Denmark during the first and second waves of the pandemic.
Lene Russell +28 more
wiley +1 more source
Interdisciplinary Medicine, EarlyView.This article evaluates the therapeutic potential of extracellular vesicle‐like particles derived from Chinese herbal medicine (CHM‐EVLP) for a range of diseases. It underscores the significance of traditional Chinese medicine in the development of innovative formulations.
Ying‐qi Cao +6 more
wiley +1 more source
DNA damage contributes to age‐associated differences in SARS‐CoV‐2 infection
Aging Cell, Volume 21, Issue 12, December 2022., 2022 Our data suggest DNA damage contributes to age‐associated differences in SARS‐CoV‐2 infection and provide a novel target for anti‐viral intervention. Abstract Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is known to disproportionately affect older individuals.
Rui Jin +14 more
wiley +1 more source
Responding to the Severe Acute Respiratory Syndrome (SARS) Outbreak: Lessons Learned in a Toronto Emergency Department. [PDF]
J Emerg Nurs, 2020 Farquharson C, Baguley K.
europepmc +1 more source
History for some or lesson for all? A systematic review and meta-analysis on the immediate and long-term mental health impact of the 2002-2003 Severe Acute Respiratory Syndrome (SARS) outbreak. [PDF]
BMC Public Health, 2021 Chau SWH +10 more
europepmc +1 more source
A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)
, 2003 Zhen-Wei Lang +8 more
openalex +1 more source
International Studies of Economics, EarlyView.Abstract In this study, we employ the synthetic control method to evaluate the transmission of external shocks, taking COVID‐19 as an example, on the stock market in the Chinese hospitality and tourism industry, specifically in the catering, hotel, cultural landscape, natural landscape, and travel agency sectors. We find an increasingly negative causal
Yuan Chen +3 more
wiley +1 more source
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials. [PDF]
Theranostics, 2021 Han YJ +24 more
europepmc +1 more source
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry [PDF]
, 2004 Graham Simmons +5 more
openalex +1 more source